JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
+$5.57B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.73B |
| 3 |
AbbVie
ABBV
|
+$1.02B |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$827M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$778M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.43B |
| 2 |
Amazon
AMZN
|
+$1.85B |
| 3 |
Cigna
CI
|
+$1.16B |
| 4 |
Microsoft
MSFT
|
+$1.08B |
| 5 |
Morgan Stanley
MS
|
+$1.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 28.67% |
| 2 | Technology | 15.47% |
| 3 | Financials | 11.13% |
| 4 | Healthcare | 9.58% |
| 5 | Consumer Discretionary | 9.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1401
Campbell Soup
CPB
$5.73B
| $31.8M | ﹤0.01% |
760,676
+382,532
| +101% | +$16.6M |
2013 Q2
33 quarters
|
|
1402
RH
RH
$2.21B
| $31.8M | ﹤0.01% |
47,652
-13,874
| -23% | -$9.55M |
2013 Q2
33 quarters
|
|
1403
Cameco
CCJ
$38.4B
| $31.7M | ﹤0.01% |
1,460,155
+78,791
| +6% | +$1.49M |
2013 Q2
33 quarters
|
|
1404
PUT
Salesforce
CRM
$189B
| $31.7M | ﹤0.01% |
116,900
+4,900
| +4% | +$1.24M |
2016 Q4
19 quarters
|
|
|
AVB
1405
PUT
DELISTED
AvalonBay Communities
AVB
| $31.6M | ﹤0.01% |
142,800
+52,800
| +59% | +$11.9M |
2021 Q1
2 quarters
|
|
|
NARI
1406
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $31.6M | ﹤0.01% |
389,240
+354,264
| +1,013% | +$29.8M |
2020 Q3
4 quarters
|
|
1407
Vanguard FTSE All-World ex-US ETF
VEU
$68.3B
| $31.5M | ﹤0.01% |
517,364
+13,638
| +3% | +$858K |
2013 Q2
33 quarters
|
|
|
SF
1408
Stifel
SF
$10.6B
| $31.5M | ﹤0.01% |
695,628
-69,297
| -9% | -$3.09M |
2013 Q2
33 quarters
|
|
1409
PTC
PTC
$21.1B
| $31.5M | ﹤0.01% |
262,877
+10,785
| +4% | +$1.44M |
2013 Q2
33 quarters
|
|
1410
iShares Select U.S. REIT ETF
ICF
$2.07B
| $31.4M | ﹤0.01% |
480,008
+39,629
| +9% | +$2.71M |
2013 Q2
33 quarters
|
|
1411
KBR
KBR
$4.46B
| $31.4M | ﹤0.01% |
796,634
-69,525
| -8% | -$2.7M |
2017 Q4
15 quarters
|
|
1412
CALL
State Street Industrial Select Sector SPDR ETF
XLI
$30.3B
| $31.3M | ﹤0.01% |
319,600
-395,200
| -55% | -$40.6M |
2017 Q4
15 quarters
|
|
|
1413
PUT
State Street Industrial Select Sector SPDR ETF
XLI
$30.3B
| $31.3M | ﹤0.01% |
+319,600
| New | +$32.8M |
2021 Q3
0 quarters
|
|
1414
City Holding Co
CHCO
$1.97B
| $31.3M | ﹤0.01% |
401,281
-45,326
| -10% | -$3.44M |
2013 Q2
33 quarters
|
|
1415
Skywest
SKYW
$3.75B
| $31.3M | ﹤0.01% |
633,539
+133,463
| +27% | +$5.81M |
2015 Q3
24 quarters
|
|
1416
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.5B
| $31.2M | ﹤0.01% |
394,417
-2,952
| -0.7% | -$240K |
2013 Q2
33 quarters
|
|
1417
SITE Centers
SITC
$163M
| $31.2M | ﹤0.01% |
2,592,848
-2,080,119
| -45% | -$25.2M |
2013 Q2
33 quarters
|
|
|
KRON
1418
DELISTED
Kronos Bio
KRON
| $31.2M | ﹤0.01% |
1,487,689
-71,499
| -5% | -$1.54M |
2020 Q4
3 quarters
|
|
1419
Rapid Micro Biosystems
RPID
$44.8M
| $31.1M | ﹤0.01% |
+1,684,232
| New | +$34.8M |
2021 Q3
0 quarters
|
|
|
DRNA
1420
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $31.1M | ﹤0.01% |
1,542,476
+110,950
| +8% | +$3.06M |
2017 Q1
18 quarters
|
|
1421
CALL
Pfizer
PFE
$161B
| $31M | ﹤0.01% |
721,100
+644,300
| +839% | +$28.5M |
2014 Q3
28 quarters
|
|
1422
FTAI Aviation
FTAI
$17.5B
| $31M | ﹤0.01% |
1,430,330
+980,840
| +218% | +$23.5M |
2021 Q1
2 quarters
|
|
1423
Duolingo
DUOL
$7.01B
| $31M | ﹤0.01% |
+186,139
| New | +$28.3M |
2021 Q3
0 quarters
|
|
1424
PUT
Clorox
CLX
$10.1B
| $30.8M | ﹤0.01% |
+185,700
| New | +$32M |
2021 Q3
0 quarters
|
|
1425
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.49B
| $30.7M | ﹤0.01% |
298,261
-8,304
| -3% | -$873K |
2013 Q2
33 quarters
|
|
Similar funds
JP Morgan Chase's Q3 2021 Portfolio in Review
As of Q3 2021, JP Morgan Chase held 7,104 positions worth $809B, down 3.5% from $838B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q3 2021 filing shows 647 new, 2,077 increased, 3,085 reduced and 500 closed positions. Its largest new stake was Toast: 2,760,295 shares worth $138M. The largest sale was Apple, an estimated $2.43B.
By sector, the portfolio is most concentrated in Miscellaneous at 29% of assets, up from 26% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q3 2021 buy was Toast: 2,760,295 shares worth $138M.
- JP Morgan Chase added most to Vanguard Short-Term Bond ETF in Q3 2021, an estimated $5.57B increase.
- JP Morgan Chase's biggest Q3 2021 reduction was Apple, cutting an estimated $2.43B.
- JP Morgan Chase fully exited Weingarten Realty Investors in Q3 2021, selling an estimated $401M.
- JP Morgan Chase's ten largest holdings make up 16% of its $809B portfolio in Q3 2021.
- JP Morgan Chase opened 647 new positions and closed 500 in Q3 2021.
- JP Morgan Chase's portfolio value fell 3.5% quarter-over-quarter to $809B.
Based on JP Morgan Chase's 13F filing for Q3 2021, filed 12 Nov 2021.